• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩中肠道微生物网络和代谢途径的改变:一项比较性16S rRNA研究

Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study.

作者信息

Liu Po-Chun, Cheng Shao-Ying, Li Chih-Chi, Wang Yu-Ke, Tseng Yufeng Jane, Kuo Ming-Che

机构信息

Cathay General Hospital, Taipei, Taiwan.

Department of Neurology, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan.

出版信息

Front Neurosci. 2025 Aug 13;19:1623165. doi: 10.3389/fnins.2025.1623165. eCollection 2025.

DOI:10.3389/fnins.2025.1623165
PMID:40880853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12380817/
Abstract

INTRODUCTION

The alterations in the gut microbial network in multiple system atrophy (MSA) remain poorly understood. This study aimed to identify key gut microbial interaction networks in MSA through comprehensive multimodal analyses.

METHODS

Demographic information and frozen fecal specimens were collected from 119 participants [MSA, = 26; Parkinson's disease (PD), = 66; healthy control (HC), = 27]. Raw amplicons of the bacterial 16S rRNA V3-V4 gene region were processed using two methods: DADA2-denoising and clustering into operational taxonomic units. We conducted univariate and multivariable analyses to assess the differential abundance of bacterial genera and predicted metabolic pathways using four statistical methods: ANCOM, ANCOM-BC, ALDEx2, and MaAsLin 2. Interbacterial interactions were assessed using four correlation and two network analyses.

RESULTS

We consistently observed lower levels of in MSA patients and lower levels of in PD patients compared with HCs (q < 0.05), both before and after adjusting for comorbidities, diet, and constipation status. The random forest classifiers effectively differentiated between MSA and PD, achieving high AUCs (0.75-0.78) in 5-fold cross-validation. A significant positive interbacterial interaction between group and was uniquely observed in MSA patients. Additionally, we identified an increase in the ARGORNPROST-PWY pathway (L-arginine degradation, q = 0.003) and a decrease in the PWY-6478 pathway (GDP-D-glycero-α-D-manno-heptose biosynthesis, q = 0.015) in MSA patients compared with HCs.

CONCLUSION

Future studies are warranted to determine whether fecal microbiome-derived signatures can serve as reliable biomarkers for MSA.

摘要

引言

多系统萎缩(MSA)患者肠道微生物网络的变化仍知之甚少。本研究旨在通过全面的多模态分析确定MSA中关键的肠道微生物相互作用网络。

方法

收集了119名参与者的人口统计学信息和冷冻粪便样本[MSA,n = 26;帕金森病(PD),n = 66;健康对照(HC),n = 27]。细菌16S rRNA V3-V4基因区域的原始扩增子使用两种方法进行处理:DADA2去噪和聚类为可操作分类单元。我们使用四种统计方法(ANCOM、ANCOM-BC、ALDEx2和MaAsLin 2)进行单变量和多变量分析,以评估细菌属的差异丰度和预测的代谢途径。使用四种相关性分析和两种网络分析评估细菌间的相互作用。

结果

在调整合并症、饮食和便秘状态前后,我们一致观察到与健康对照相比,MSA患者的[具体细菌名称1]水平较低,PD患者的[具体细菌名称2]水平较低(q < 0.05)。随机森林分类器能够有效区分MSA和PD,在5折交叉验证中获得了较高的AUC(0.75 - 0.78)。在MSA患者中独特地观察到[细菌组名称]组和[另一细菌名称]之间存在显著的正细菌间相互作用。此外,与健康对照相比,我们发现MSA患者中ARGORNPROST-PWY途径(L-精氨酸降解,q = 0.003)增加,PWY-6478途径(GDP-D-甘油-α-D-甘露庚糖生物合成,q = 0.015)减少。

结论

未来有必要进行研究以确定粪便微生物组衍生特征是否可作为MSA的可靠生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/ff6639b3fb20/fnins-19-1623165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/4ee81c9c4400/fnins-19-1623165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/56304840794f/fnins-19-1623165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/7ee877454862/fnins-19-1623165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/ff6639b3fb20/fnins-19-1623165-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/4ee81c9c4400/fnins-19-1623165-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/56304840794f/fnins-19-1623165-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/7ee877454862/fnins-19-1623165-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3cc/12380817/ff6639b3fb20/fnins-19-1623165-g004.jpg

相似文献

1
Altered gut microbial networks and metabolic pathways in multiple system atrophy: a comparative 16S rRNA study.多系统萎缩中肠道微生物网络和代谢途径的改变:一项比较性16S rRNA研究
Front Neurosci. 2025 Aug 13;19:1623165. doi: 10.3389/fnins.2025.1623165. eCollection 2025.
2
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
3
16S rRNA gene amplicon sequencing for microbiota analysis of rumen fluid, feces, and milk of Sarda sheep fed different content of alfalfa hay (Medicago sativa).对饲喂不同苜蓿干草(紫花苜蓿)含量的撒丁岛绵羊的瘤胃液、粪便和乳汁进行微生物群分析的16S rRNA基因扩增子测序。
J Dairy Sci. 2025 Jul 7. doi: 10.3168/jds.2024-26172.
4
The association between gut microbiota composition and cardiometabolic parameters in healthy adults.健康成年人肠道微生物群组成与心脏代谢参数之间的关联。
BMC Microbiol. 2025 Aug 14;25(1):505. doi: 10.1186/s12866-025-04261-4.
5
Characteristic alterations of gut microbiota and metabolites in patients with perianal abscess: a multi-omics analysis.肛周脓肿患者肠道微生物群和代谢物的特征性改变:一项多组学分析
Front Microbiol. 2025 Jul 17;16:1557972. doi: 10.3389/fmicb.2025.1557972. eCollection 2025.
6
Unveiling the diagnostic and pro-inflammatory role of crohn's disease: insights from 16 S-guided discovery and species-specific validation.揭示克罗恩病的诊断和促炎作用:来自16S引导发现和物种特异性验证的见解
BMC Gastroenterol. 2025 Jul 1;25(1):468. doi: 10.1186/s12876-025-04061-0.
7
Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.非囊性纤维化支气管扩张症成年患者的粪便微生物组和代谢组改变。
Respir Res. 2022 Nov 19;23(1):317. doi: 10.1186/s12931-022-02229-w.
8
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.分析 speculate 性中枢神经系统丰富细胞外囊泡中的生物标志物在帕金森病中的应用:一项全面的系统评价和诊断荟萃分析。
J Neurol. 2024 Apr;271(4):1680-1706. doi: 10.1007/s00415-023-12093-3. Epub 2023 Dec 16.
9
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.
10
Significant associations between high-risk sexual behaviors and enterotypes of gut microbiome in HIV-negative men who have sex with men.在与男性发生性行为的HIV阴性男性中,高危性行为与肠道微生物群的肠型之间存在显著关联。
mSphere. 2025 Jun 25:e0023225. doi: 10.1128/msphere.00232-25.

本文引用的文献

1
The Gut-Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications.帕金森病中的肠-脑轴:新兴概念与治疗意义
Mov Disord Clin Pract. 2025 Mar 13. doi: 10.1002/mdc3.70029.
2
Beneficial effects of GABA-producing potential probiotic Limosilactobacillus fermentum L18 of human origin on intestinal permeability and human gut microbiota.来源于人的产 GABA 潜能益生菌发酵乳杆菌 L18 对肠道通透性和人类肠道微生物群的有益作用。
Microb Cell Fact. 2023 Dec 12;22(1):256. doi: 10.1186/s12934-023-02264-2.
3
Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy.
了解多系统萎缩中胃肠功能障碍的潜在原因。
Neurobiol Dis. 2023 Oct 15;187:106296. doi: 10.1016/j.nbd.2023.106296. Epub 2023 Sep 14.
4
Gut-to-brain spreading of pathology in synucleinopathies: A focus on molecular signalling mediators.在突触核蛋白病中,病理学从肠道向大脑传播:聚焦于分子信号转导介质。
Behav Brain Res. 2023 Aug 24;452:114574. doi: 10.1016/j.bbr.2023.114574. Epub 2023 Jul 8.
5
Gut microbiome dysbiosis across early Parkinson's disease, REM sleep behavior disorder and their first-degree relatives.肠道微生物组失调与早期帕金森病、快速眼动睡眠行为障碍及其一级亲属。
Nat Commun. 2023 May 2;14(1):2501. doi: 10.1038/s41467-023-38248-4.
6
Ruminococcus gnavus: friend or foe for human health.瘤胃球菌属:人类健康的朋友还是敌人。
FEMS Microbiol Rev. 2023 Mar 10;47(2). doi: 10.1093/femsre/fuad014.
7
Genetic correlations between Alzheimer's disease and gut microbiome genera.阿尔茨海默病与肠道微生物属之间的遗传相关性。
Sci Rep. 2023 Mar 31;13(1):5258. doi: 10.1038/s41598-023-31730-5.
8
normalizes blood-brain barrier dysfunction and neurodevelopment deficits associated with prenatal exposure to lipopolysaccharide.使与脂多糖产前暴露相关的血脑屏障功能障碍和神经发育缺陷正常化。
Gut Microbes. 2023 Jan-Dec;15(1):2178800. doi: 10.1080/19490976.2023.2178800.
9
The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease.肠道细菌在炎症性肠病中的诊断和预后潜力。
Gut Microbes. 2023 Jan-Dec;15(1):2176118. doi: 10.1080/19490976.2023.2176118.
10
The gut microbiota in multiple sclerosis varies with disease activity.多发性硬化症患者的肠道微生物群与疾病活动度有关。
Genome Med. 2023 Jan 5;15(1):1. doi: 10.1186/s13073-022-01148-1.